David B. Ridley
- Economics and Econometrics top 2%
- Public Health, Environmental and Occupational Health
- Pharmacology top 10%
- Management of Technology and Innovation top 5%
- Immunology
- Co-authors
- Henry G. GrabowskiMargaret KyleKevin A. SchulmanStéphane A. RégnierEli LiebmanKirsten AxelsenPeter ArcidiaconoPaul B. Ellickson
- Topics
- Pharmaceutical Economics and Policy (23 papers)Health Systems, Economic Evaluations, Quality of Life (10 papers)Healthcare Policy and Management (9 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
David B. Ridley
36 papers receiving 510 citations
Peers
Comparison fields: 5 of 94
- Economics and Econometrics 411
- Public Health, Environmental and Occupational Health 94
- Pharmacology 79
- Management of Technology and Innovation 76
- Immunology 61
Countries citing papers authored by David B. Ridley
This map shows the geographic impact of David B. Ridley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Ridley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Ridley more than expected).
Fields of papers citing papers by David B. Ridley
This network shows the impact of papers produced by David B. Ridley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Ridley. The network helps show where David B. Ridley may publish in the future.
Co-authorship network of co-authors of David B. Ridley
This figure shows the co-authorship network connecting the top 25 collaborators of David B. Ridley. A scholar is included among the top collaborators of David B. Ridley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Ridley. David B. Ridley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 6 | |
| 5 | 7 | |
| 6 | 7 | |
| 7 | 2 | |
| 8 | 13 | |
| 9 | 29 | |
| 10 | 9 | |
| 11 | 4 | |
| 12 | 22 | |
| 13 | 4 | |
| 14 | 42 | |
| 15 | 21 | |
| 16 | 10 | |
| 17 | 126 | |
| 18 | 32 | |
| 19 | 2 | |
| 20 | 17 |
About David B. Ridley
David B. Ridley is a scholar working on Economics and Econometrics, Pharmacology and Management of Technology and Innovation, having authored 39 papers that have together received 546 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (23 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Healthcare Policy and Management (9 papers). The work is most often cited by research in Economics and Econometrics (411 citations), Management of Technology and Innovation (76 citations) and Pharmacology (79 citations). David B. Ridley has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Henry G. Grabowski, Margaret Kyle, Kevin A. Schulman, Stéphane A. Régnier, Eli Liebman, Kirsten Axelsen, Peter Arcidiacono, Paul B. Ellickson, Ali Yürükoğlu and Xiaoshu Bei. Their work appears in journals such as The Lancet, Nature Reviews Drug Discovery and The Review of Economics and Statistics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.